{"id":6822,"date":"2023-05-17T02:49:36","date_gmt":"2023-05-17T02:49:36","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=6822"},"modified":"2023-08-29T17:57:56","modified_gmt":"2023-08-29T17:57:56","slug":"prescient-therapeutics-present-omnicar-cellpryme-international-gene-therapy-conference","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=6822","title":{"rendered":"Prescient Therapeutics\u5c06\u5728\u56fd\u9645\u57fa\u56e0\u6cbb\u7597\u4f1a\u8bae\u4e0a\u5c55\u793aOmniCAR\u548cCellPryme\u7684\u8bba\u6587\u6458\u8981"},"content":{"rendered":"<p>\u4e34\u5e8a\u9636\u6bb5\u7684\u80bf\u7624\u516c\u53f8Prescient Therapeutics (ASX: PTX) \u5c06\u5728\u672c\u6708\u665a\u4e9b\u65f6\u5019\u5728\u6cd5\u56fd\u4e3e\u884c\u7684International Society of Cell &amp; Gene Therapy (ISCT) \u5e74\u4f1a\u4e0a\u63d0\u4ea4\u5176\u4e24\u4efd\u6458\u8981\u3002<\/p>\n<p>Prescient\u7684\u7814\u7a76\u4eba\u5458\u5c06\u5c55\u793a\u8be5\u516c\u53f8\u7684<a href=\"http:\/\/smallcaps-production.test\/prescient-therapeutics-enters-strategic-collaboration-renowned-cancer-centre-us\/?lang=cn\">\u4e0b\u4e00\u4ee3\u514d\u75ab\u53d7\u4f53\u5e73\u53f0OmniCAR<\/a>\u548c<a href=\"http:\/\/smallcaps-production.test\/prescient-therapeutics-debuts-cellpryme-a-worlds-largest-car-tcr-meeting-boston\/?lang=cn\">\u7ec6\u80de\u6cbb\u7597\u589e\u5f3a\u5e73\u53f0CellPryme\u7684\u65b0\u4e34\u5e8a\u524d\u6570\u636e<\/a>\u3002<\/p>\n<p>\u8fd9\u4e24\u4efd\u6458\u8981\u8fd8\u5c06\u53d1\u8868\u5728\u4e0b\u4e00\u671fISCT\u7684\u5b98\u65b9\u671f\u520a\u300aCytotherapy\u300b\u4e0a\u3002<\/p>\n<p>ISCT\u4e13\u6ce8\u4e8e\u57fa\u4e8e\u7ec6\u80de\u548c\u57fa\u56e0\u7684\u6cbb\u7597\u53d1\u5c55\u7684\u4e34\u5e8a\u524d\u548c\u8f6c\u5316\u65b9\u9762\uff0c\u65e8\u5728\u63a8\u52a8\u79d1\u5b66\u7814\u7a76\u4e3a\u60a3\u8005\u63d0\u4f9b\u521b\u65b0\u7684\u6cbb\u7597\u3002<\/p>\n<p>\u8be5\u5e74\u5ea6\u4f1a\u8bae\u6c47\u96c6\u4e86\u4e34\u5e8a\u533b\u751f\u3001\u76d1\u7ba1\u673a\u6784\u3001\u7814\u7a76\u4eba\u5458\u548c\u884c\u4e1a\u5408\u4f5c\u4f19\u4f34\uff0c\u4ed6\u4eec\u7684\u5171\u540c\u613f\u666f\u662f\u5c06\u7ec6\u80de\u548c\u57fa\u56e0\u6280\u672f\u8f6c\u5316\u4e3a\u5b89\u5168\u548c\u6709\u6548\u7684\u6cbb\u7597\u65b9\u6cd5\u3002<\/p>\n<p>\u5b83\u6bcf\u5e74\u5438\u5f15\u4e86\u6765\u81ea60\u4e2a\u56fd\u5bb6\u76842700\u591a\u540d\u4e13\u5bb6\u3002<\/p>\n<h2>\u8363\u5e78\u5730\u5c55\u793a<\/h2>\n<p>Prescient\u516c\u53f8\u603b\u7ecf\u7406Steven Yatomi-Clarke\u8bf4\uff0c\u8be5\u516c\u53f8\u5f88\u8363\u5e78\u80fd\u5728ISCT\u7684\u4ee3\u8868\u9762\u524d\u5c55\u793a\u3002<\/p>\n<p>&#8220;\u4ed6\u8bf4\uff1a&#8221;\u6709\u4e24\u4efd\u6458\u8981\u88ab\u8fd9\u4e2a\u8457\u540d\u7684\u4f1a\u8bae\u63a5\u53d7\uff0c\u8bc1\u660e\u4e86\u6211\u4eec\u79d1\u5b66\u7684\u8d28\u91cf\u548c\u65b0\u9896\u6027\uff0c\u4e5f\u4f53\u73b0\u4e86OmniCAR\u548cCellPryme\u5e73\u53f0\u662f\u5982\u4f55\u5b9a\u4f4d\u5728\u7ec6\u80de\u6cbb\u7597\u5b9e\u7528\u6027\u548c\u521b\u65b0\u7684\u6700\u524d\u6cbf\u3002<\/p>\n<p>\u79d1\u5b66\u4e8b\u52a1\u9ad8\u7ea7\u526f\u603b\u88c1Rebecca Lim\u535a\u58eb\u8bf4\uff0c\u8fd9\u6b21\u4f1a\u8bae\u5c06\u4f7fPrescient\u6709\u673a\u4f1a\u8c08\u8bba\u5176\u80bf\u7624\u5b66\u7ec4\u5408\u7684\u53d1\u5c55\u3002<\/p>\n<p>&#8220;\u5979\u8bf4\uff1a&#8221;\u6211\u4eec\u5728OmniCAR\u548cCellPryme\u5e73\u53f0\u7684\u5f00\u53d1\u65b9\u9762\u53d6\u5f97\u4e86\u91cd\u5927\u8fdb\u5c55\uff0c\u8fd9\u4e9b\u5e73\u53f0\u6709\u53ef\u80fd\u63a8\u52a8\u7ec6\u80de\u7597\u6cd5\u7684\u6548\u7528\u548c\u5229\u7528\u3002<\/p>\n<p>&#8220;ISCT\u4f1a\u8bae\u662f\u4e00\u4e2a\u7edd\u4f73\u7684\u673a\u4f1a\uff0c\u53ef\u4ee5\u5411\u7814\u7a76\u4eba\u5458\u3001\u4e34\u5e8a\u533b\u751f\u548c\u5236\u836f\u4e1a\u4ee3\u8868\u7ec4\u6210\u7684\u7ec6\u80de\u6cbb\u7597\u4e13\u5bb6\u89c2\u4f17\u5c55\u793a[\u6211\u4eec\u7684\u7814\u7a76]\u6570\u636e\u3002&#8221;<\/p>\n<h2>\u8463\u4e8b\u4f1a\u4efb\u547d<\/h2>\n<p>\u672c\u5468\u65e9\u4e9b\u65f6\u5019\uff0cPrescient\u516c\u53f8\u5ba3\u5e03\u4efb\u547dEllen Feigal\u535a\u58eb\u4e3a\u7f8e\u56fd\u7684\u72ec\u7acb\u975e\u6267\u884c\u8463\u4e8b\u3002<\/p>\n<p>Feigal\u535a\u58eb\u76ee\u524d\u662f\u5168\u7403\u751f\u547d\u79d1\u5b66\u54a8\u8be2\u516c\u53f8NDA Partners\u7684\u5408\u4f19\u4eba\u548c\u751f\u7269\u5236\u54c1\u8d1f\u8d23\u4eba\uff0c\u5979\u5728\u90a3\u91cc\u9886\u5bfc\u8bbe\u8ba1\u548c\u6267\u884c\u7ec6\u80de\u7597\u6cd5\u3001\u533b\u5b66\u6210\u50cf\u3001\u8840\u6db2\u5b66\u548c\u80bf\u7624\u5b66\u9886\u57df\u7684\u4ea7\u54c1\u5f00\u53d1\u548c\u76d1\u7ba1\u6218\u7565\u3002<\/p>\n<p>\u5979\u4e5f\u662f\u4e9a\u5229\u6851\u90a3\u5dde\u7acb\u5927\u5b66 (Arizona State University)\u00a0Sandra Day O\u2019Connor College of Law\u7684\u517c\u804c\u6559\u5e08\uff0c\u6559\u6388\u533b\u5b66\u7814\u7a76\u4f26\u7406\u548c\u6cd5\u5f8b\u3002<\/p>\n<p>Feigal\u535a\u58eb\u66fe\u662fCalifornia Institute of Regenerative Medicine\u7684\u9ad8\u7ea7\u526f\u603b\u88c1\uff08\u7814\u7a76\u548c\u5f00\u53d1\uff09\uff1bAmgen Inc\u5b89\u8fdb\u516c\u53f8\u7684\u6267\u884c\u533b\u7597\u603b\u76d1\uff08\u5168\u7403\u5f00\u53d1\uff09\uff1bTranslational Genomics Research Institute\u7684\u526f\u603b\u88c1\uff08\u4e34\u5e8a\u79d1\u5b66\uff09\uff1b\u4ee5\u53caUS National Cancer Institute\u764c\u75c7\u6cbb\u7597\u548c\u8bca\u65ad\u90e8\u95e8\u7684\u4e3b\u4efb\u3002<\/p>\n<p>\u5979\u662f\u751f\u7269\u6280\u672f\u516c\u53f8Xencor Inc\u7684\u8463\u4e8b\u4f1a\u6210\u5458\u548c\u764c\u75c7\u514d\u75ab\u6cbb\u7597\u516c\u53f8NextCure\u7684\u8463\u4e8b\u3002<\/p>\n<h2>\u6b63\u786e\u7684\u6280\u80fd\u7ec4\u5408<\/h2>\n<p>Prescient\u516c\u53f8\u4e3b\u5e2dSteve Engle\u8bf4\uff0cFeigal\u535a\u58eb\u7684\u4efb\u547d\u786e\u4fdd\u4e86\u8463\u4e8b\u4f1a\u62e5\u6709\u9002\u5f53\u7684\u6280\u80fd\u7ec4\u5408\u3001\u591a\u6837\u6027\u548c\u72ec\u7acb\u6027\u3002<\/p>\n<p>&#8220;\u4ed6\u8bf4\uff1a&#8221;Ellen\u662f\u4e00\u4f4d\u6210\u529f\u7684\u884c\u4e1a\u9886\u8896\uff0c\u5728\u7f8e\u56fd\u548c\u5168\u7403\u7684\u65b0\u7ec6\u80de\u6cbb\u7597\u5546\u4e1a\u5316\u65b9\u9762\u6709\u7740\u826f\u597d\u7684\u8bb0\u5f55\u3002<\/p>\n<p>\u4ed6\u8bf4\uff1a&#8221;\u968f\u7740Prescient\u516c\u53f8\u63a5\u8fd1<a href=\"http:\/\/smallcaps-production.test\/prescient-therapeutics-ptx-100-promising-results-clinical-t-cell-lymphoma-trial\/?lang=cn\">[\u4e3b\u5bfc\u836f\u7269]PTX-100<\/a>\u7684\u4e34\u5e8a\u8f6c\u6298\u70b9\uff0c\u4ee5\u53caOmniCAR\u548cCellPryme\u7684\u8fdb\u5c55\uff0c\u5979\u5bf9\u764c\u75c7\u6cbb\u7597\u76d1\u7ba1\u9014\u5f84\u3001\u5236\u9020\u548c\u5e02\u573a\u7684\u6df1\u523b\u8fd0\u8425\u7406\u89e3\u5c06\u662f\u975e\u5e38\u6709\u4ef7\u503c\u7684\u3002&#8221;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u4e34\u5e8a\u9636\u6bb5\u7684\u80bf\u7624\u516c\u53f8Prescient Therapeutics (ASX: PTX) \u5c06\u5728\u672c\u6708\u665a\u4e9b\u65f6\u5019\u5728\u6cd5\u56fd\u4e3e\u884c\u7684International Society of Cell &amp; Gene Therapy (ISCT) \u5e74\u4f1a\u4e0a\u63d0\u4ea4\u5176\u4e24\u4efd\u6458\u8981\u3002 Prescient\u7684\u7814\u7a76\u4eba\u5458\u5c06\u5c55\u793a\u8be5\u516c\u53f8\u7684\u4e0b\u4e00\u4ee3\u514d\u75ab\u53d7\u4f53\u5e73\u53f0OmniCAR\u548c\u7ec6\u80de\u6cbb\u7597\u589e\u5f3a\u5e73\u53f0CellPryme\u7684\u65b0\u4e34\u5e8a\u524d\u6570\u636e\u3002 \u8fd9\u4e24\u4efd\u6458\u8981\u8fd8\u5c06\u53d1\u8868\u5728\u4e0b\u4e00\u671fISCT\u7684\u5b98\u65b9\u671f\u520a\u300aCytotherapy\u300b\u4e0a\u3002 ISCT\u4e13\u6ce8\u4e8e\u57fa\u4e8e\u7ec6\u80de\u548c\u57fa\u56e0\u7684\u6cbb\u7597\u53d1\u5c55\u7684\u4e34\u5e8a\u524d\u548c\u8f6c\u5316\u65b9\u9762\uff0c\u65e8\u5728\u63a8\u52a8\u79d1\u5b66\u7814\u7a76\u4e3a\u60a3\u8005\u63d0\u4f9b\u521b\u65b0\u7684\u6cbb\u7597\u3002 \u8be5\u5e74\u5ea6\u4f1a\u8bae\u6c47\u96c6\u4e86\u4e34\u5e8a\u533b\u751f\u3001\u76d1\u7ba1\u673a\u6784\u3001\u7814\u7a76\u4eba\u5458\u548c\u884c\u4e1a\u5408\u4f5c\u4f19\u4f34\uff0c\u4ed6\u4eec\u7684\u5171\u540c\u613f\u666f\u662f\u5c06\u7ec6\u80de\u548c\u57fa\u56e0\u6280\u672f\u8f6c\u5316\u4e3a\u5b89\u5168\u548c\u6709\u6548\u7684\u6cbb\u7597\u65b9\u6cd5\u3002 \u5b83\u6bcf\u5e74\u5438\u5f15\u4e86\u6765\u81ea60\u4e2a\u56fd\u5bb6\u76842700\u591a\u540d\u4e13\u5bb6\u3002 \u8363\u5e78\u5730\u5c55\u793a Prescient\u516c\u53f8\u603b\u7ecf\u7406Steven Yatomi-Clarke\u8bf4\uff0c\u8be5\u516c\u53f8\u5f88\u8363\u5e78\u80fd\u5728ISCT\u7684\u4ee3\u8868\u9762\u524d\u5c55\u793a\u3002 &#8220;\u4ed6\u8bf4\uff1a&#8221;\u6709\u4e24\u4efd\u6458\u8981\u88ab\u8fd9\u4e2a\u8457\u540d\u7684\u4f1a\u8bae\u63a5\u53d7\uff0c\u8bc1\u660e\u4e86\u6211\u4eec\u79d1\u5b66\u7684\u8d28\u91cf\u548c\u65b0\u9896\u6027\uff0c\u4e5f\u4f53\u73b0\u4e86OmniCAR\u548cCellPryme\u5e73\u53f0\u662f\u5982\u4f55\u5b9a\u4f4d\u5728\u7ec6\u80de\u6cbb\u7597\u5b9e\u7528\u6027\u548c\u521b\u65b0\u7684\u6700\u524d\u6cbf\u3002 \u79d1\u5b66\u4e8b\u52a1\u9ad8\u7ea7\u526f\u603b\u88c1Rebecca Lim\u535a\u58eb\u8bf4\uff0c\u8fd9\u6b21\u4f1a\u8bae\u5c06\u4f7fPrescient\u6709\u673a\u4f1a\u8c08\u8bba\u5176\u80bf\u7624\u5b66\u7ec4\u5408\u7684\u53d1\u5c55\u3002 &#8220;\u5979\u8bf4\uff1a&#8221;\u6211\u4eec\u5728OmniCAR\u548cCellPryme\u5e73\u53f0\u7684\u5f00\u53d1\u65b9\u9762\u53d6\u5f97\u4e86\u91cd\u5927\u8fdb\u5c55\uff0c\u8fd9\u4e9b\u5e73\u53f0\u6709\u53ef\u80fd\u63a8\u52a8\u7ec6\u80de\u7597\u6cd5\u7684\u6548\u7528\u548c\u5229\u7528\u3002 &#8220;ISCT\u4f1a\u8bae\u662f\u4e00\u4e2a\u7edd\u4f73\u7684\u673a\u4f1a\uff0c\u53ef\u4ee5\u5411\u7814\u7a76\u4eba\u5458\u3001\u4e34\u5e8a\u533b\u751f\u548c\u5236\u836f\u4e1a\u4ee3\u8868\u7ec4\u6210\u7684\u7ec6\u80de\u6cbb\u7597\u4e13\u5bb6\u89c2\u4f17\u5c55\u793a[\u6211\u4eec\u7684\u7814\u7a76]\u6570\u636e\u3002&#8221; \u8463\u4e8b\u4f1a\u4efb\u547d \u672c\u5468\u65e9\u4e9b\u65f6\u5019\uff0cPrescient\u516c\u53f8\u5ba3\u5e03\u4efb\u547dEllen Feigal\u535a\u58eb\u4e3a\u7f8e\u56fd\u7684\u72ec\u7acb\u975e\u6267\u884c\u8463\u4e8b\u3002 Feigal\u535a\u58eb\u76ee\u524d\u662f\u5168\u7403\u751f\u547d\u79d1\u5b66\u54a8\u8be2\u516c\u53f8NDA Partners\u7684\u5408\u4f19\u4eba\u548c\u751f\u7269\u5236\u54c1\u8d1f\u8d23\u4eba\uff0c\u5979\u5728\u90a3\u91cc\u9886\u5bfc\u8bbe\u8ba1\u548c\u6267\u884c\u7ec6\u80de\u7597\u6cd5\u3001\u533b\u5b66\u6210\u50cf\u3001\u8840\u6db2\u5b66\u548c\u80bf\u7624\u5b66\u9886\u57df\u7684\u4ea7\u54c1\u5f00\u53d1\u548c\u76d1\u7ba1\u6218\u7565\u3002 \u5979\u4e5f\u662f\u4e9a\u5229\u6851\u90a3\u5dde\u7acb\u5927\u5b66 (Arizona State University)\u00a0Sandra Day O\u2019Connor College of Law\u7684\u517c\u804c\u6559\u5e08\uff0c\u6559\u6388\u533b\u5b66\u7814\u7a76\u4f26\u7406\u548c\u6cd5\u5f8b\u3002 Feigal\u535a\u58eb\u66fe\u662fCalifornia Institute of Regenerative Medicine\u7684\u9ad8\u7ea7\u526f\u603b\u88c1\uff08\u7814\u7a76\u548c\u5f00\u53d1\uff09\uff1bAmgen Inc\u5b89\u8fdb\u516c\u53f8\u7684\u6267\u884c\u533b\u7597\u603b\u76d1\uff08\u5168\u7403\u5f00\u53d1\uff09\uff1bTranslational Genomics Research Institute\u7684\u526f\u603b\u88c1\uff08\u4e34\u5e8a\u79d1\u5b66\uff09\uff1b\u4ee5\u53caUS National Cancer Institute\u764c\u75c7\u6cbb\u7597\u548c\u8bca\u65ad\u90e8\u95e8\u7684\u4e3b\u4efb\u3002 \u5979\u662f\u751f\u7269\u6280\u672f\u516c\u53f8Xencor Inc\u7684\u8463\u4e8b\u4f1a\u6210\u5458\u548c\u764c\u75c7\u514d\u75ab\u6cbb\u7597\u516c\u53f8NextCure\u7684\u8463\u4e8b\u3002 \u6b63\u786e\u7684\u6280\u80fd\u7ec4\u5408&hellip; <a class=\"more-link\" href=\"https:\/\/smallcapscn.x5view.co\/?p=6822\">Continue reading <span class=\"screen-reader-text\">Prescient Therapeutics\u5c06\u5728\u56fd\u9645\u57fa\u56e0\u6cbb\u7597\u4f1a\u8bae\u4e0a\u5c55\u793aOmniCAR\u548cCellPryme\u7684\u8bba\u6587\u6458\u8981<\/span><\/a><\/p>\n","protected":false},"author":4,"featured_media":18942,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[171],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Prescient Therapeutics\u5c06\u5728\u56fd\u9645\u57fa\u56e0\u6cbb\u7597\u4f1a\u8bae\u4e0a\u5c55\u793aOmniCAR\u548cCellPryme\u7684\u8bba\u6587\u6458\u8981<\/title>\n<meta name=\"description\" content=\"\u4e34\u5e8a\u9636\u6bb5\u7684\u80bf\u7624\u516c\u53f8Prescient Therapeutics (ASX: PTX) \u5c06\u5728\u672c\u6708\u665a\u4e9b\u65f6\u5019\u5728\u6cd5\u56fd\u4e3e\u884c\u7684International Society of Cell &amp; Gene Therapy (ISCT) \u5e74\u4f1a\u4e0a\u63d0\u4ea4\u5176\u4e24\u4efd\u6458\u8981\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prescient Therapeutics\u5c06\u5728\u56fd\u9645\u57fa\u56e0\u6cbb\u7597\u4f1a\u8bae\u4e0a\u5c55\u793aOmniCAR\u548cCellPryme\u7684\u8bba\u6587\u6458\u8981\" \/>\n<meta property=\"og:description\" content=\"\u4e34\u5e8a\u9636\u6bb5\u7684\u80bf\u7624\u516c\u53f8Prescient Therapeutics (ASX: PTX) \u5c06\u5728\u672c\u6708\u665a\u4e9b\u65f6\u5019\u5728\u6cd5\u56fd\u4e3e\u884c\u7684International Society of Cell &amp; Gene Therapy (ISCT) \u5e74\u4f1a\u4e0a\u63d0\u4ea4\u5176\u4e24\u4efd\u6458\u8981\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-present-omnicar-cellpryme-international-gene-therapy-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-17T02:49:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:57:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Prescient-Therapeutics-ASX-PTX-OmniCAR-CellPryme-abstracts-conference-International-Society-of-Cell-Gene-Therapy-ISCT-France-2023.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Imelda Cotton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imelda Cotton\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-present-omnicar-cellpryme-international-gene-therapy-conference\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-present-omnicar-cellpryme-international-gene-therapy-conference\/\",\"name\":\"Prescient Therapeutics\u5c06\u5728\u56fd\u9645\u57fa\u56e0\u6cbb\u7597\u4f1a\u8bae\u4e0a\u5c55\u793aOmniCAR\u548cCellPryme\u7684\u8bba\u6587\u6458\u8981\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2023-05-17T02:49:36+00:00\",\"dateModified\":\"2023-08-29T17:57:56+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\"},\"description\":\"\u4e34\u5e8a\u9636\u6bb5\u7684\u80bf\u7624\u516c\u53f8Prescient Therapeutics (ASX: PTX) \u5c06\u5728\u672c\u6708\u665a\u4e9b\u65f6\u5019\u5728\u6cd5\u56fd\u4e3e\u884c\u7684International Society of Cell & Gene Therapy (ISCT) \u5e74\u4f1a\u4e0a\u63d0\u4ea4\u5176\u4e24\u4efd\u6458\u8981\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-present-omnicar-cellpryme-international-gene-therapy-conference\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-present-omnicar-cellpryme-international-gene-therapy-conference\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-present-omnicar-cellpryme-international-gene-therapy-conference\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prescient Therapeutics\u5c06\u5728\u56fd\u9645\u57fa\u56e0\u6cbb\u7597\u4f1a\u8bae\u4e0a\u5c55\u793aOmniCAR\u548cCellPryme\u7684\u8bba\u6587\u6458\u8981\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\",\"name\":\"Imelda Cotton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"caption\":\"Imelda Cotton\"},\"description\":\"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=4\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Prescient Therapeutics\u5c06\u5728\u56fd\u9645\u57fa\u56e0\u6cbb\u7597\u4f1a\u8bae\u4e0a\u5c55\u793aOmniCAR\u548cCellPryme\u7684\u8bba\u6587\u6458\u8981","description":"\u4e34\u5e8a\u9636\u6bb5\u7684\u80bf\u7624\u516c\u53f8Prescient Therapeutics (ASX: PTX) \u5c06\u5728\u672c\u6708\u665a\u4e9b\u65f6\u5019\u5728\u6cd5\u56fd\u4e3e\u884c\u7684International Society of Cell & Gene Therapy (ISCT) \u5e74\u4f1a\u4e0a\u63d0\u4ea4\u5176\u4e24\u4efd\u6458\u8981\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Prescient Therapeutics\u5c06\u5728\u56fd\u9645\u57fa\u56e0\u6cbb\u7597\u4f1a\u8bae\u4e0a\u5c55\u793aOmniCAR\u548cCellPryme\u7684\u8bba\u6587\u6458\u8981","og_description":"\u4e34\u5e8a\u9636\u6bb5\u7684\u80bf\u7624\u516c\u53f8Prescient Therapeutics (ASX: PTX) \u5c06\u5728\u672c\u6708\u665a\u4e9b\u65f6\u5019\u5728\u6cd5\u56fd\u4e3e\u884c\u7684International Society of Cell & Gene Therapy (ISCT) \u5e74\u4f1a\u4e0a\u63d0\u4ea4\u5176\u4e24\u4efd\u6458\u8981\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-present-omnicar-cellpryme-international-gene-therapy-conference\/","og_site_name":"smallcapsCN","article_published_time":"2023-05-17T02:49:36+00:00","article_modified_time":"2023-08-29T17:57:56+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Prescient-Therapeutics-ASX-PTX-OmniCAR-CellPryme-abstracts-conference-International-Society-of-Cell-Gene-Therapy-ISCT-France-2023.jpg","type":"image\/jpeg"}],"author":"Imelda Cotton","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Imelda Cotton"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-present-omnicar-cellpryme-international-gene-therapy-conference\/","url":"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-present-omnicar-cellpryme-international-gene-therapy-conference\/","name":"Prescient Therapeutics\u5c06\u5728\u56fd\u9645\u57fa\u56e0\u6cbb\u7597\u4f1a\u8bae\u4e0a\u5c55\u793aOmniCAR\u548cCellPryme\u7684\u8bba\u6587\u6458\u8981","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2023-05-17T02:49:36+00:00","dateModified":"2023-08-29T17:57:56+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e"},"description":"\u4e34\u5e8a\u9636\u6bb5\u7684\u80bf\u7624\u516c\u53f8Prescient Therapeutics (ASX: PTX) \u5c06\u5728\u672c\u6708\u665a\u4e9b\u65f6\u5019\u5728\u6cd5\u56fd\u4e3e\u884c\u7684International Society of Cell & Gene Therapy (ISCT) \u5e74\u4f1a\u4e0a\u63d0\u4ea4\u5176\u4e24\u4efd\u6458\u8981\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-present-omnicar-cellpryme-international-gene-therapy-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-present-omnicar-cellpryme-international-gene-therapy-conference\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-present-omnicar-cellpryme-international-gene-therapy-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Prescient Therapeutics\u5c06\u5728\u56fd\u9645\u57fa\u56e0\u6cbb\u7597\u4f1a\u8bae\u4e0a\u5c55\u793aOmniCAR\u548cCellPryme\u7684\u8bba\u6587\u6458\u8981"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e","name":"Imelda Cotton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","caption":"Imelda Cotton"},"description":"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.","url":"https:\/\/smallcapscn.x5view.co\/?author=4"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6822"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6822"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6822\/revisions"}],"predecessor-version":[{"id":20620,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6822\/revisions\/20620"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/18942"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6822"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6822"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}